Broadening Inflation Pressures Beyond Energy and Geopolitical Shocks BP Ousts Chairman Amid Allegations of Bullying Conduct Core Scientific Targets 15 GW Power Capacity at Muskogee Campus in Major Expansion Plan Nasa Taps Blue Origin for First Uncrewed Lunar Mission as 20bn Moon Base Plans Move Forward Microsoft Appoints Trusted Technology Lead to Bridge Speed and Responsibility in AI Development Equinor Receives Analyst Upgrade Amid Tightening European Gas Market Banco Macro SA BMA Q4 2025 Earnings Strong EPS Beat Overshadowed by Broader Market Headwinds DPRO Q1 2026 Earnings EPS Misses Estimates by Narrow Margin Stock Gains on Optimism Around Operational Progress JVA Q4 2019 Earnings Coffee Holding Co Misses EPS Estimates by Wide Margin ESS Tech Inc GWH Q1 2026 Earnings Significant EPS Miss Amidst Revenue Disconnect Stock Gains 386 ATO Q1 2026 Earnings EPS Beat Amid Natural Gas Utility Strength NFT Limited MI Q3 2018 Earnings Massive EPS Miss Sends Stock Sharply Lower GPAct III Acquisition Corp GPAT Holds Steady Near NAV with Modest Uptick Helmerich Payne HP Edges Higher as Stock Holds Above Key Support National CineMedia NCMI Holds Steady Near Support Amid Modest Decline EW Scripps SSP Struggles Near Support as Media Sector Headwinds Persist PEBK Holds Steady Peoples Bancorp of North Carolina Trades Near Resistance With Modest Gains APWC Q3 1997 Earnings EPS Misses Estimates as Stock Rises Despite Headwinds CMS Energy Corporation 5875 Junior Subordinated Notes due 2078 CMSC Q1 2026 Earnings Common Share EPS Beat Drives Modest Note Price Decline UFPT Q1 2026 Earnings EPS Misses Estimates but Shares Edge Higher ORKT Q0 2024 Earnings Substantial EPS Miss as Revenue Remains Undisclosed RXO Reports Continued Surge in Truckload Spot Market During Second Quarter Minerva Neurosciences Q1 2026 Earnings EPS Misses Street Estimates Stock Gains on Pipeline Optimism CocaCola and Procter Gamble Two Dividend Stocks Under LongTerm Focus NOA Q1 2026 Earnings EPS Misses Estimates But Stock Rises 225 on Resilient Operations Travere Therapeutics TVTX Hovers Near Resistance as Slight Dip Tests Support Levels